MissionIR Articles
-
VistaGen Therapeutics (VSTA) and CATO BioVentures Sign Strategic Business Development Agreement for CNS Products
VistaGen Therapeutics Inc., a biopharmaceutical company applying leading embryonic stem cell technology to discover and develop novel treatments for central nervous system disorders, diabetes and cardiovascular disease, and Cato BioVentures, the venture capital affiliate of…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Establishes Permanent Philadelphia Headquarters with 5-Year Lease at One Commerce Square
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Reports Q3 2025 Net Income of $1.5 Million and 42% Gross Margin, Highlighting Strong Operational Turnaround
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Launches HOPE Therapeutics’ One-Day TMS Protocol for Treatment-Resistant Depression in Florida
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Files Defamation Lawsuit Against Wolfpack Research and Founder Dan David
- MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) CEO Discusses AI-Driven Cancer Drug Development in FintechTV Interview at NYSE